Table of Contents
Table of Contents
Preface
Prescription Pain Reliever Abuse: Agencies Have Begun Coordinating Education Efforts, but Need to Assess Effectiveness
(GAO)
Prescription Drug Control: DEA Has Enhanced Efforts to Combat Diversion, but Could Better Assess and Report Program Results
(GAO)
Statement of Michele M. Leonhart, Administrator, Drug Enforcement Administration. Hearing on “Responding to the Prescription Drug Epidemic: Strategies for Reducing Abuse, Misuse, Diversion and Fraud”
Statement of John L. Eadie, Director, Prescription Monitoring Program Center of Excellence, Brandeis University. Hearing on “Responding to the Prescription Drug Epidemic: Strategies for Reducing Abuse, Misuse, Diversion and Fraud”
Index
